Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
PUT
Allegiant Air
ALGT
$2.35B
| $422K | ﹤0.01% |
+2,200
| New | +$394K |
|
3652
Archrock
AROC
$5.84B
| $422K | ﹤0.01% |
12,783
-13,491
| -51% | -$411K |
|
3653
PUT
American Eagle Outfitters
AEO
$2.74B
| $420K | ﹤0.01% |
24,700
-394,000
| -94% | -$6M |
|
3654
ESCO Technologies
ESE
$7.76B
| $420K | ﹤0.01% |
11,095
+1,168
| +12% | +$43.8K |
|
3655
Magna International
MGA
$18.7B
| $419K | ﹤0.01% |
7,908
+5,198
| +192% | +$268K |
|
3656
CALL
Olin
OLN
$2.13B
| $419K | ﹤0.01% |
13,100
+1,400
| +12% | +$37.5K |
|
3657
CALL
Qorvo
QRVO
$8.54B
| $419K | ﹤0.01% |
+5,305
| New | +$378K |
|
|
SAFM
3658
DELISTED
Sanderson Farms Inc
SAFM
| $419K | ﹤0.01% |
5,303
-629
| -11% | -$51K |
|
|
WY.PRA
3659
DELISTED
WEYERHAEUSER COMP PREF CONV SER A (WA)
WY.PRA
| $419K | ﹤0.01% |
+7,755
| New | +$444K |
|
3660
Cato Corp
CATO
$65.9M
| $418K | ﹤0.01% |
10,722
-13,838
| -56% | -$588K |
|
|
PGNX
3661
PUT
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $418K | ﹤0.01% |
83,500
+79,400
| +1,937% | +$500K |
|
3662
CALL
Infosys
INFY
$49.3B
| $417K | ﹤0.01% |
47,600
-124,800
| -72% | -$1.1M |
|
|
PBT
3663
Permian Basin Royalty Trust
PBT
$1.56B
| $417K | ﹤0.01% |
52,140
-5,851
| -10% | -$55.3K |
|
3664
Essent Group
ESNT
$6.18B
| $416K | ﹤0.01% |
18,053
+483
| +3% | +$11.6K |
|
3665
CALL
Ingredion
INGR
$6.55B
| $416K | ﹤0.01% |
5,400
-1,900
| -26% | -$155K |
|
|
MDP
3666
DELISTED
Meredith Corporation
MDP
| $416K | ﹤0.01% |
7,567
-5,583
| -42% | -$300K |
|
3667
CALL
Ubiquiti
UI
$35B
| $415K | ﹤0.01% |
14,300
-40,600
| -74% | -$1.2M |
|
|
YOKU
3668
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
| $414K | ﹤0.01% |
34,510
-100,169
| -74% | -$1.64M |
|
3669
CALL
Factset
FDS
$9.9B
| $413K | ﹤0.01% |
2,600
+200
| +8% | +$30K |
|
|
HTS
3670
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $413K | ﹤0.01% |
22,920
+7,889
| +52% | +$144K |
|
|
RPRX
3671
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
| $412K | ﹤0.01% |
51,500
-71,400
| -58% | -$639K |
|
3672
HubSpot
HUBS
$10.5B
| $411K | ﹤0.01% |
10,564
+10,237
| +3,131% | +$382K |
|
3673
CALL
MBIA
MBI
$251M
| $411K | ﹤0.01% |
45,700
-182,200
| -80% | -$1.62M |
|
|
RPRX
3674
DELISTED
Repros Therapeutics Inc.
RPRX
| $411K | ﹤0.01% |
51,500
-77,185
| -60% | -$690K |
|
3675
PUT
Cracker Barrel
CBRL
$1.3B
| $410K | ﹤0.01% |
2,700
-2,400
| -47% | -$339K |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.